News | RIVM

Seasonal flu epidemic in the Netherlands

The flu epidemic in the Netherlands has started. The number of people with flu (influenza) increased significantly in the past two weeks.

Flu epidemic seems to be emerging

More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.

Flu jab for additional groups

The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons

Launch of the European project RISK-HUNT3R

The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.

Last winter’s flu epidemic was short and mild. And then COVID-19 arrived.

The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.

De griepepidemie in de winter van 2019/2020 was mild en duurde slechts 5 weken.

Mild 2018-2019 influenza epidemic

The annual influenza epidemic in the winter of 2018-2019 was less severe than the year before. Approximately 400,000 people have had the flu.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Animal-free innovations in safety assessment of chemicals

How can the process of validation, acceptance and use of animal-free innovative approaches to assess the safety of chemicals be facilitated?

Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination

Influenza vaccination reduces the number of influenza virus infections but not the overall number of illness.

Risks of potential release of genetically modified mosquitoes evaluated

On Saba, a Dutch Caribbean island, diseases such as dengue, chikungunya and zika can be reduced by the use of genetically modified mosquitoes.